Jupiter Neurosciences (JUNS) Market Capitalization (2024 - 2026)

Jupiter Neurosciences (JUNS) has reported Market Capitalization for 3 consecutive years, with $139580.7 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 70.53% year-over-year to $139580.7 in Q2 2026; TTM through Jun 2026 was $139580.7, a 70.53% decrease from a year earlier, with the FY2025 full-year figure at $468347.3, down 90.08% from the prior year.
• Market Capitalization was $139580.7 for Q2 2026 at Jupiter Neurosciences, down from $468347.3 in the prior quarter.
• Over five years, Market Capitalization peaked at $4.7 million in Q4 2024 and troughed at $139580.7 in Q2 2026.
• A 3-year average of $1.1 million and a median of $470975.3 in 2025 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization slumped 90.08% in 2025 and plunged 70.53% in 2026, its largest moves.
• Over 3 years, Market Capitalization stood at $4.7 million in 2024, then tumbled by 90.08% to $468347.3 in 2025, then slumped by 70.2% to $139580.7 in 2026.
• The last three Market Capitalization figures came in at $139580.7 (Q2 2026), $468347.3 (Q4 2025), and $804564.6 (Q3 2025), per Business Quant data.